“The Trump administration on Wednesday is launching an effort to reimagine the way clinical trials are designed, with a goal of drastically reducing the time and money it takes to develop new drugs…
The effort — dubbed the Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS) program — features teams selected through a bidding process that will bring drug candidates through experimental clinical trial processes…
Today, developing a drug can take longer than a decade and cost around $2 billion. More than 90% of drug candidates fail, according to HHS.”
From Axios.
